260 related articles for article (PubMed ID: 8594987)
1. An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor.
Foxall C; Holme KR; Liang W; Wei Z
Anal Biochem; 1995 Nov; 231(2):366-73. PubMed ID: 8594987
[TBL] [Abstract][Full Text] [Related]
2. Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor.
Dimitrellos V; Lamari FN; Militsopoulou M; Kanakis I; Karamanos NK
Biomed Chromatogr; 2003 Jan; 17(1):42-7. PubMed ID: 12583005
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
[TBL] [Abstract][Full Text] [Related]
4. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach.
Najjam S; Gibbs RV; Gordon MY; Rider CC
Cytokine; 1997 Dec; 9(12):1013-22. PubMed ID: 9417813
[TBL] [Abstract][Full Text] [Related]
6. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
7. Basic fibroblast growth factor-binding domain of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis.
Morita H; Shinzato T; David G; Mizutani A; Habuchi H; Fujita Y; Ito M; Asai J; Maeda K; Kimata K
Lab Invest; 1994 Oct; 71(4):528-35. PubMed ID: 7967508
[TBL] [Abstract][Full Text] [Related]
8. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
9. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglycans-mediated pathway: an ultrastructural approach.
Gleizes PE; Noaillac-Depeyre J; Amalric F; Gas N
Eur J Cell Biol; 1995 Jan; 66(1):47-59. PubMed ID: 7750519
[TBL] [Abstract][Full Text] [Related]
11. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate in the inner limiting membrane of embryonic chicken retina binds basic fibroblast growth factor to promote axonal outgrowth.
Chai L; Morris JE
Exp Neurol; 1999 Nov; 160(1):175-85. PubMed ID: 10630202
[TBL] [Abstract][Full Text] [Related]
13. The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRalpha1.
Rickard SM; Mummery RS; Mulloy B; Rider CC
Glycobiology; 2003 Jun; 13(6):419-26. PubMed ID: 12626395
[TBL] [Abstract][Full Text] [Related]
14. A method for the non-covalent immobilization of heparin to surfaces.
Mahoney DJ; Whittle JD; Milner CM; Clark SJ; Mulloy B; Buttle DJ; Jones GC; Day AJ; Short RD
Anal Biochem; 2004 Jul; 330(1):123-9. PubMed ID: 15183770
[TBL] [Abstract][Full Text] [Related]
15. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.
Kure S; Yoshie O
J Immunol; 1986 Dec; 137(12):3900-8. PubMed ID: 2431047
[TBL] [Abstract][Full Text] [Related]
16. Opticin binds to heparan and chondroitin sulfate proteoglycans.
Hindson VJ; Gallagher JT; Halfter W; Bishop PN
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4417-23. PubMed ID: 16303928
[TBL] [Abstract][Full Text] [Related]
17. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
18. Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2.
van den Born J; Pikas DS; Pisa BJ; Eriksson I; Kjellen L; Berden JH
Glycobiology; 2003 Jan; 13(1):1-10. PubMed ID: 12634318
[TBL] [Abstract][Full Text] [Related]
19. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
Rudd TR; Uniewicz KA; Ori A; Guimond SE; Skidmore MA; Gaudesi D; Xu R; Turnbull JE; Guerrini M; Torri G; Siligardi G; Wilkinson MC; Fernig DG; Yates EA
Org Biomol Chem; 2010 Dec; 8(23):5390-7. PubMed ID: 20865198
[TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding.
Wang H; Toida T; Kim YS; Capila I; Hileman RE; Bernfield M; Linhardt RJ
Biochem Biophys Res Commun; 1997 Jun; 235(2):369-73. PubMed ID: 9199199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
